Product Images Clonidine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Clonidine NDC 75907-023 by Dr. Reddy's Labratories Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

chemical-structure - clonidine 01

chemical-structure - clonidine 01

cross-section - clonidine 02

cross-section - clonidine 02

Figure-1 - clonidine 03 figure1

Figure-1 - clonidine 03 figure1

Figure-2-L - clonidine 04 figure2 L

Figure-2-L - clonidine 04 figure2 L

This text provides information about the Clonidine Transdermal System, which delivers 0.1 mg per day for one week. It warns against undergoing an MRI with the patch on to avoid burns. The system contains 3.09 mg of Clonidine along with various inactive ingredients. The product is intended for use as prescribed (Rx Only) and manufactured by Dr. Reddy's Laboratories.*

Figure-2-R - clonidine 05 figure2 R

Figure-2-R - clonidine 05 figure2 R

This text provides information about an adhesive cover that does not contain active medication and should be applied over a patch, if necessary. It also mentions that suggestions for usage can be found in the patient information sheet.*

Figure-3 - clonidine 06 figure3

Figure-3 - clonidine 06 figure3

Figure-4 - clonidine 07 figure4

Figure-4 - clonidine 07 figure4

Figure-5 - clonidine 08 figure5

Figure-5 - clonidine 08 figure5

Figure-6 - clonidine 09 figure6

Figure-6 - clonidine 09 figure6

Principle Display Panel 0.2mg - clonidine 10 PDP0.2mg

Principle Display Panel 0.2mg - clonidine 10 PDP0.2mg

This is a description of a Clonidine Transdermal System USP for delivering 0.2 mg per day over the course of one week. It contains specific instructions such as removing the patch before an MRI procedure to avoid burns. The package includes 4 systems and 4 adhesive covers. The transdermal system contains 6.19 mg of clonidine and lists inactive ingredients. It is for transdermal use only, and the usual dosage information can be found in the package insert. The medication should be kept out of reach of children and stored at 20° to 25°C. The product is distributed by Dr. Reddy's Laboratories in Princeton.*

principle display panel 0.1mg - clonidine 11 pdp0.1mg

principle display panel 0.1mg - clonidine 11 pdp0.1mg

This is a description of Clonidine Transdermal System USP delivering 0.1 mg/day for one week. Each system contains 3.09 mg of clonidine. It includes instructions such as removing the patch before an MRI, storing at 20-25°C, and keeping out of reach of children. The system consists of 4 systems and 4 adhesive covers with programmed delivery. Inactive ingredients include aluminum, silicon dioxide, and mineral oil. The text specifies it is for transdermal use only with dosage details provided in the package insert.*

principle display panel 0.3mg - clonidine 12 pdp0.3mg

principle display panel 0.3mg - clonidine 12 pdp0.3mg

This text provides useful information about Clonidine Transdermal System USP, including the dosage of 0.3 mg/day, instructions for use, and precautions such as avoiding MRI procedures with the patch on to prevent burns. It also lists the inactive ingredients and storage instructions. The product is distributed by Dr. Reddy's Laboratories and contains 4 systems and 4 adhesive covers.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.